Swedish investment platform Cardeon develops Scandinavian innovative startups and early-stage ventures in medical technology and Life Science. The most interesting innovations springing from research at the world class academic institutions in Medicon Valley and across Scandinavia is accessed from Cardeons head office in Lund, Sweden. Cardeon transforms the early innovations into commercial products that fulfill significant unmet therapeutic and diagnostic needs. The results enhance the abilities of health care system, improves the well-being of people across the globe and saves lives.

In parallel, the ventures are capitalized and developed to well-established listed companies. This provides public investors with access to early venture investments and creates superior co-investor value along the lifetime of the investments.      

History

Cardeon was founded in 2018 by Masoud Khayyami to create a platform to further develop his existing holdings such as Spectracure, Lumito and Prolight Diagnostics. The high-quality deal flow stemming from academic innovations in the region has allowed for a rapid expansion of the portfolio and attracted outstanding Board of Directors, Senior partners and investment organization.